DaVita
DVA
#2205
Rank
NZ$14.42 B
Marketcap
NZ$201.80
Share price
-0.32%
Change (1 day)
-25.20%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2025 (TTM): NZ$17.16

According to DaVita's latest financial reports the company's current EPS (TTM) is NZ$17.19. In 2024 the company made an earnings per share (EPS) of NZ$19.08 an increase over its 2023 EPS that were of NZ$13.16.

EPS history for DaVita from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$17.16-10.06%
2024NZ$19.0844.94%
2023NZ$13.1627.26%
2022NZ$10.34-35.56%
2021NZ$16.0544.1%
2020NZ$11.1419.7%
2019NZ$9.31540.48%
2018NZ$1.45-76.07%
2017NZ$6.07-19.31%
2016NZ$7.52242.52%
2015NZ$2.20-62.87%
2014NZ$5.9213.43%
2013NZ$5.228.45%
2012NZ$4.81

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Tenet Healthcare
THC
NZ$25.43 47.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
NZ$3.28-80.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Universal Health Services
UHS
NZ$36.93 114.79%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
NZ$17.73 3.12%๐Ÿ‡บ๐Ÿ‡ธ USA